New Imaging Method for Cancer Treatment
Novel applications and translation of [18F]hGTS13, a system xc- specific radiopharmaceutical
This work explores a new way to take pictures of cancer to help doctors choose the best treatments that make cancer cells self-destruct.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-11131229 on NIH RePORTER |
What this research studies
We are developing a special imaging agent that can highlight certain features in cancer cells. This agent helps us see if cancer cells are vulnerable to a unique process called ferroptosis, which causes them to die. By using this imaging method, doctors could identify which cancers might respond well to treatments designed to trigger ferroptosis. It also helps track how well these new treatments are working in patients.
Who could benefit from this research
Good fit: Patients with certain types of cancer that might be susceptible to ferroptosis-inducing therapies could potentially benefit from this imaging approach.
Not a fit: Patients whose cancers do not exhibit the specific characteristics targeted by this imaging agent or ferroptosis-inducing treatments may not receive direct benefit.
Why it matters
Potential benefit: If successful, this could lead to more personalized and effective cancer treatments by guiding doctors to therapies that specifically target a cancer's weaknesses.
How similar studies have performed: Targeting ferroptosis in cancer is a rapidly growing area of interest, and this novel imaging agent aims to advance its clinical application.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Beinat, Corinne — Stanford University
- Study coordinator: Beinat, Corinne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.